Bank Julius Baer & Co. Ltd, Zurich Hepion Pharmaceuticals, Inc. Transaction History

Bank Julius Baer & Co. Ltd, Zurich

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$1.39 - $2.1 $18,252 - $27,575	-13,131 Closed	0 $0
Q2 2021 Jul 23, 2021	BUY	$1.56 - $2.26 $204 - $296	131 Added 1.01%	13,131 $26,000
Q1 2021 May 10, 2021	BUY	$1.77 - $2.98 $8,462 - $14,247	4,781 Added 58.17%	13,000 $24,000
Q4 2020 Feb 24, 2021	BUY	$1.58 - $3.64 $12,565 - $28,948	7,953 Added 2989.85%	8,219 $18,000
Q4 2020 Feb 12, 2021	BUY	$1.58 - $3.64 $420 - $968	266 New	266 $18,000

Ticker HEPA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,229,600
Market Cap $57.2M
Description
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver...

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.